A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction

Xiaohu Tang, Kathleen I. Seyb, Mickey Huang, Eli R. Schuman, Ping Shi, Haining Zhu, Marcie A. Glicksman

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Aberrant protein-protein interactions are attractive drug targets in a variety of neurodegenerative diseases due to the common pathology of accumulation of protein aggregates. In amyotrophic lateral sclerosis, mutations in SOD1 cause the formation of aggregates and inclusions that may sequester other proteins and disrupt cellular processes. It has been demonstrated that mutant SOD1, but not wild-type SOD1, interacts with the axonal transport motor dynein and that this interaction contributes to motor neuron cell death, suggesting that disrupting this interaction may be a potential therapeutic target. However, it can be challenging to configure a high-throughput screening (HTS)-compatible assay to detect inhibitors of a protein-protein interaction. Here we describe the development and challenges of an HTS for small-molecule inhibitors of the mutant SOD1-dynein interaction. We demonstrate that the interaction can be formed by coexpressing the A4V mutant SOD1 and dynein intermediate complex in cells and that this interaction can be disrupted by compounds added to the cell lysates. Finally, we show that some of the compounds identified from a pilot screen to inhibit the protein-protein interaction with this method specifically disrupt the interaction between the dynein complex and mtSOD1 but not the dynein complex itself when applied to live cells.

Original languageEnglish (US)
Pages (from-to)314-326
Number of pages13
JournalJournal of Biomolecular Screening
Issue number3
StatePublished - Mar 2012
Externally publishedYes


  • CNS and PNS diseases
  • cell-based assays
  • fluorescence methods
  • protein-protein interactions

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction'. Together they form a unique fingerprint.

Cite this